Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01414426
Title Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications

oral cavity cancer

Therapies

Vandetanib

Age Groups: adult
Covered Countries USA


No variant requirements are available.